Siiltibcy

· Serum Life Science Europe GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Siiltibcy, covering 2025-10-24 to 2025-10-24. Get the full timeline:

Most recent: EMA Authorised: Siiltibcy (Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10)) — Serum Life Science Europe GmbH